Skip to content

Clinical trials

Psychotic Disorders trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20072
20092
20101
20111
20121
20172
20201
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alkermes, Inc.2
Janssen Research & Development, LLC2
AstraZeneca1
Brigham and Women's Hospital1
Chonbuk National University Hospital1
Eli Lilly and Company1
Janssen Korea, Ltd., Korea1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Korea Otsuka Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders18
Schizophrenia13
Alzheimer Disease2
Brain Diseases1
Central Nervous System Diseases1
Dementia1
Hallucinations1
Mental Disorders1
Metabolic Syndrome1
Nervous System Diseases1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.